Supreme Court Reinstates Trump Travel Ban
Bob Grant | Jun 26, 2017
The judges’ decision allows exceptions that may permit scientists’ travel from the blocked countries.
ISTOCK, PHILLIP NELSON
Supreme Court Nominee Draws Concern from Environmentalists
Supreme Court Nominee Draws Concern from Environmentalists
President Trump’s pick, Judge Brett Kavanaugh, has often opposed court involvement in environmental and health regulations.
President Trump’s pick, Judge Brett Kavanaugh, has often opposed court involvement in environmental and health regulations.
Myriad, Post Mortem
The Scientist Staff | Jun 1, 2016
David Schwartz of the Illinois Institute of Technology-Chicago, Kent College of Law, discusses the impact of the US Supreme Court unanimously striking down Myriad Genetics' patent of human BRCA genes and tests to detect mutations in them.
Governing Science
Abby Olena | Dec 31, 2013
How the US government impacted life science research in 2013
Criminal Hype
Kerry Grens | Sep 25, 2013
Overstating the benefits of a drug lands a former biotech executive in home detention.
Speaking of Science
The Scientist Staff | Aug 1, 2013
August 2013's selection of notable quotes
Another Lawsuit over Genetic Tests
Kate Yandell | Jul 11, 2013
Myriad Genetics, the company originally behind tests for the cancer-associated BRCA mutations, is suing two competitors for patent infringement.
Speaking of Science
The Scientist Staff | Jul 1, 2013
July 2013's selection of notable quotes
Gene Patents Decision: Everybody Wins
Jeffrey M. Perkel | Jun 18, 2013
Last week’s Supreme Court decision to invalidate patents on human genes was a win for patients, independent researchers, and even the wider biotech industry.
Opinion: On Patenting Genes
Joan Ellis | Jun 18, 2013
The scientific community and the impact of the Myriad Genetics Supreme Court decision